Elvenite's recent wins with TINE and Blentagruppen reinforce our positive H2 outlook for CombinedX. We retain our SEK37.5 Base Case, with heavy ERP exposure remaining attractive at a discount to peers
ANNONS
Elvenite's recent wins with TINE and Blentagruppen reinforce our positive H2 outlook for CombinedX. We retain our SEK37.5 Base Case, with heavy ERP exposure remaining attractive at a discount to peers
